JO
MIRA icon

John Overdeck’s MIRA Pharmaceuticals MIRA Stock Holding History

John Overdeck’s Portfolio MIRA Stock Details MIRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-27,044
Closed -$40.8K – 4794
2025
Q4 		$40.8K Sell
27,044
-18,659
-41% -$27.4K ﹤0.01% 3954
2025
Q3 		$62.2K Buy
45,703
+25,816
+130% +$37.5K ﹤0.01% 3523
2025
Q2 		$24.1K Sell
19,887
-2,487
-11% -$2.87K ﹤0.01% 3108
2025
Q1 		$21.9K Sell
22,374
-1,943
-8% -$2.21K ﹤0.01% 3094
2024
Q4 		$27.7K Buy
+24,317
New +$31.8K ﹤0.01% 3086

Other funds holding MIRA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CSI
Cross Staff Investments Pittsford, New York $178M AUM 21.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SEM
Suncoast Equity Management Tampa, Florida $798M AUM 14.62% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
FAB
First American Bank Dundee, Illinois $1.79B AUM 30.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

John Overdeck's MIRA Position: Q1 2026 in Review

John Overdeck sold out of MIRA Pharmaceuticals (MIRA) in Q1 2026, closing a stake of 27,044 shares — an estimated $40.8K sold.

John Overdeck first reported a position in MIRA in Q4 2024 and held it in 5 quarters. The position peaked at $62.2K in Q3 2025. 26 funds tracked by Wall St. Rank hold MIRA as of Q1 2026.

  • John Overdeck reported no remaining MIRA Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • John Overdeck sold 27,044 MIRA Pharmaceuticals shares in Q1 2026, an estimated $40.8K.
  • John Overdeck first reported a position in MIRA Pharmaceuticals in Q4 2024 and held it in 5 quarters.
  • John Overdeck's MIRA Pharmaceuticals position peaked at $62.2K in Q3 2025.
  • 26 funds tracked by Wall St. Rank held MIRA Pharmaceuticals as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.